Evidence map›Paper›PMID 35974801›Full record

ArticleInternational journal of general medicine2022

Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Xiaoman Hu, Xincheng Li, Huifen Xu, Weili Zheng, Jian Wang, Wenyu Wang, Senxu Li, Ning Zhang, Yunpeng Wang, Kaiyu Han

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xiaoman HuDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.ORCID 0000-0003-4428-3631
Xincheng LiDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Huifen XuDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Weili ZhengDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Jian WangDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Wenyu WangDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Senxu LiDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Ning ZhangDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Yunpeng WangDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Kaiyu HanDepartment of Respiratory and Critical Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aims to establish a risk prediction model for muscular calf vein thrombosis (MCVT) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: The research sample consisted of 248 patients with AECOPD and all of them underwent vascular ultrasounds of both lower limbs in this retrospective study. Univariate analysis and multivariate logistic regression analysis were conducted on factors with significant group differences to screen for the independent risk factors of MCVT. A nomogram to predict the risk of MCVT was constructed and validated with bootstrap resampling. Results: According to the exclusion criteria, 240 patients were included for analysis, divided into the MCVT group (n = 81) and the non-MCVT group (n = 159). Multivariate logistic regression analyses showed that hypertension, elevated MPV, reduced albumin (ALB), elevated D-dimer and bed rest ≥3 days were independent risk factors for MCVT in AECOPD. A nomogram model for predicting AECOPD with MCVT was established based on them. The area under the curve (AUC) of receiver operating characteristic (ROC) curve for the prediction model and the simplified Wells score was 0.784 (95% CI: 0.722-0.847) and 0.659 (95% CI: 0.583-0.735), respectively. The cut-off value and Youden index of prediction model were 0.248 and 0.454, respectively. At the same time, the sensitivity, specificity, positive predictive value, and negative predictive value of the prediction model were 85.9%, 59.5%, 84.6%, and 77.4%, respectively. The sensitivity and specificity of the simplified Wells score were 67.9% and 56.3%, respectively. Validation by the use of bootstrap resampling revealed optimal discrimination and calibration, and the decision analysis curve (DAC) suggested that this prediction model involved high clinical practicability. Conclusion: We developed a nomogram that can predict the risk of MCVT for AECOPD patients. This model has the potential to assist clinicians in making treatment recommendations and formulating corresponding prevention measures.

Indexed as

acute exacerbation of chronic obstructive pulmonary diseasemodelmuscular calf vein thrombosisnomogramrisk factors

Identifiers

PMID35974801
PMCPMC9375990
OpenAlexW4293403514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.